Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3033

Actual shortage: 243 (8%)
Anticipated shortage: 15 (0%)
Avoided shortage: 9 (0%)
Resolved: 2766 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

32 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-01 2024-01-12 212371
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-08 2024-03-15 221717
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2021-05-28 2021-08-03 140066
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2021-10-22 2021-10-29 147806
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2022-09-16 2022-10-07 169519
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2022-11-11 2022-12-05 174343
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2023-03-09 2023-04-21 186572
PIPERACILLIN AND TAZOBACTAM FOR INJECTION 2G 0.25G POWDER FOR SOLUTION Actual shortage 2017-03-11 2018-09-12 583
CEFEPIME FOR INJECTION 2G POWDER FOR SOLUTION Actual shortage 2017-03-12 2017-10-05 698
APO-CEFEPIME 2G POWDER FOR SOLUTION Resolved 2019-07-31 2019-08-02 90341
APO-CEFEPIME 2G POWDER FOR SOLUTION Resolved 2019-12-05 2020-02-18 100265
APO-CEFEPIME 2G POWDER FOR SOLUTION Resolved 2021-06-11 2021-08-06 140772
APO-CEFEPIME 2G POWDER FOR SOLUTION Resolved 2021-09-17 2021-10-25 145822
APO-CEFEPIME 2G POWDER FOR SOLUTION Resolved 2024-02-23 2024-03-01 220444
APO-LOPERAMIDE 2MG TABLET Actual shortage 2017-03-10 2017-10-05 372
APO-TOLTERODINE 2MG TABLET Resolved 2017-03-11 2017-11-07 519
APO-TOLTERODINE 2MG TABLET Resolved 2017-03-11 2018-02-28 523
APO-ALPRAZ TS 2MG TABLET Resolved 2017-06-07 2017-10-24 12241
APO-HALOPERIDOL LIQ 2MG/ML 2MG SOLUTION Actual shortage 2017-08-13 2017-10-05 18957
APO-SALVENT STERULES 2MG SOLUTION Actual shortage 2017-08-13 2017-10-05 19063

Showing 1661 to 1680 of 3033

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-AMOXI SUGAR FREE 125MG POWDER FOR SUSPENSION Discontinued 2018-09-07 2018-09-15 60249
APO NAPROXEN TAB 125MG 125MG TABLET Discontinued 2018-09-08 2019-08-08 60663
APO-HYDROMORPHONE CR 12MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110962
APO-NIZATIDINE 150MG CAPSULE Discontinued 2017-03-13 2017-03-13 1127
APO-SULIN TAB 150MG 150mg tablet Discontinued 2017-03-13 2017-03-13 1186
APO-CLINDAMYCIN 150MG CAPSULE To be discontinued 2018-09-07 2018-12-28 60396
APO-IRBESARTAN 150MG TABLET Discontinued 2018-09-07 2018-12-28 60536
APO-LAMIVUDINE 150MG TABLET Discontinued 2018-09-07 2019-07-13 60557
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2018-09-08 2019-02-13 60723
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2018-09-08 2018-12-28 60726
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2019-01-02 2019-01-09 70810
ACID REDUCER 150MG TABLET Discontinued 2019-01-04 2019-01-04 71210
APO-IRBESARTAN 150MG TABLET Discontinued 2019-01-04 2019-01-04 71234
APO-CLINDAMYCIN 150MG CAPSULE Discontinued 2019-11-11 2019-11-11 98363
APO-OXAZEPAM 15MG TABLET To be discontinued 2018-09-08 2018-09-08 60678
APO-TEMAZEPAM 15MG CAPSULE Discontinued 2018-10-23 2019-01-14 65477
APO-PINDOL TAB 15MG 15MG TABLET Discontinued 2022-02-09 2022-12-09 154574
APO-SOTALOL 160MG TABLET Discontinued 2017-03-31 2018-02-05 4971
APO-CANDESARTAN 16MG TABLET Discontinued 2018-09-07 2018-09-15 60313
APO-CANDESARTAN 16MG TABLET Discontinued 2018-09-07 2018-09-15 60316

Showing 121 to 140 of 356